Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04532112 · ClinicalTrials.gov registry record · NA
Biocontainment Device for Aerosol Generating Procedures
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT04532112: Completed NA study, sponsored by University of Pennsylvania.
NCT04532112 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04532112, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The primary goal of this study is to assess use of a biocontainment device for planned airway procedures under general anesthesia. This will serve as a platform for using this device as a novel biocontainment and aerosol evacuation system as part of rapid sequence intubation protocols for COVID-19 patients. We hypothesize that airway procedures with the aerosol biocontainment device will be safe and effective with airway procedure times approaching times for airway procedures without the device.
Interventions
- DEVICE Biocontainment Device For Aerosol Generating Procedures (Biobox)
- DEVICE Control for aerosol generating procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-12-07 |
| Est. Completion | 2021-09-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04532112
The ClinicalTrials.gov registry entry for NCT04532112 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biocontainment Device For Aerosol Generating Procedures (Biobox) is the first listed.
NCT04532112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04532112 about?
NCT04532112 is a clinical study titled "Biocontainment Device for Aerosol Generating Procedures". The primary goal of this study is to assess use of a biocontainment device for planned airway procedures under general anesthesia. This will serve as a platform for using this device as a novel biocontainment and aerosol evacuation system as part of rapid sequence intubation protocols for COVID-19 p...
What is the current status of trial NCT04532112?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2020-12-07. Estimated completion is 2021-09-03.
What interventions are being tested in trial NCT04532112?
The interventions under investigation include: Biocontainment Device For Aerosol Generating Procedures (Biobox) (DEVICE), Control for aerosol generating procedures (DEVICE).
Who is sponsoring clinical trial NCT04532112?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.